Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Colorectal Neoplasms 7Solid Tumor Cancer 1Rectal Neoplasms 1Neoplasm Metastasis 1Metastatic Gastric Adenocarcinoma 1HER2 IHC3+ Advanced Colorectal Cancer 1Colonic Neoplasms 1Carcinoma 1Adenocarcinoma 1

Interventions

Oxaliplatin 9Capecitabine 9Paclitaxel 7Fluorouracil 7pembrolizumab 6Leucovorin 6Cisplatin 5zolbetuximab 4Docetaxel 4trastuzumab deruxtecan 3enzalutamide 3durvalumab 3cemiplimab 3Trastuzumab 3Nivolumab 3Irinotecan 3Gemcitabine 3Albumin-Bound Paclitaxel 3fludarabine 2darolutamide 2atezolizumab 2Taxes 2Ramucirumab 2Radiotherapy, Image-Guided 2Radiosurgery 2Pemetrexed 2Cyclophosphamide 2Carboplatin 2130-nm albumin-bound paclitaxel 2vistusertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma × Trifluridine × 90 days × Clear all
NCT04879368 2026-06-10

INTEGRATEIIb

Australasian Gastro-Intestinal Trials Group

Phase 3 Completed
462 enrolled 15 charts
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡